newsfilter
← Latest News
GlobeNewswire·

Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference

  • Korro Bio, Inc. (NASDAQ: KRRO) announced that CEO Ram Aiyar, Ph.D., along with COO Todd Chappell and CSO Loic Vincent, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference.
  • The presentation is scheduled for Thursday, January 15, 2026, at 10:30 a.m. PT (1:30 p.m. ET).
  • A live webcast of the event will be available on the "Events & Presentations" page of Korro's website, with a replay accessible for 30 days post-presentation.
  • Korro is a Cambridge, Massachusetts-based biopharmaceutical company developing genetic medicines that edit RNA rather than DNA to achieve precise, transient, single-base edits.
  • The company utilizes an oligonucleotide-based approach leveraging proprietary platforms, established manufacturing know-how, & precedented delivery modalities for rare & prevalent diseases.
  • Korro intends to disclose material nonpublic information via its Investor Relations website, LinkedIn, & X (Twitter) to comply with Regulation FD obligations.